BACKGROUND Some concerns still have not been resolved about the long-term safety of drug-eluting stents (DES)
Platelet activation is increased in patients with STEMI (7, 8) . Moreover, a delay in arterial healing has been recognized at the culprit site in patients with STEMI compared with patients treated for stable angina (9) . Percutaneous coronary intervention (PCI) in STEMI patients is therefore associated with a higher risk of stent thrombosis (ST) (10) (11) (12) .
Comparisons of new-generation DES (n-DES) and
bare-metal stents (BMS) in the STEMI setting (13) (14) (15) are limited. The available data on the outcome of PCI in STEMI patients are mainly based on comparisons of old-generation DES (o-DES) and BMS (16) (17) (18) (19) (20) (21) (22) .
The objective of this study was to evaluate the ST rate up to 3 years in patients with STEMI treated by PCI with n-DES compared with BMS and o-DES documented in a national registry with complete consecutive enrollment, the SCAAR (Swedish Coronary Angiography and Angioplasty Registry). 
METHODS

All consecutive patients in
RESULTS
During the study period, 34,147 patients with STEMI were treated by PCI with n-DES (n ¼ 4,811), o-DES (n ¼ 4,271), or BMS (n ¼ 25,065). The relative distribution of n-DES, o-DES, and BMS during the study period is described in Figure 1 .
Baseline characteristics are listed in Table 1 . The clinical risk profile was higher in the DES groups compared with the BMS group with no relevant differences between the n-DES and o-DES groups.
Procedural characteristics are shown in Table 2 .
Ticagrelor was more often used in the o-DES group, whereas lower use of bivalirudin was observed in the BMS group. Also, glycoprotein IIb/IIIa inhibitors were more often used with BMS.
The assumption of proportionality of the hazards for ST during the 3-year follow-up period was not met significant difference between n-DES and o-DES in the risk of early/late ST (Fig. 3, Table 3 ). (Fig. 3, Table 3 ). 
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FIGURE 2 Cumulative Rates of Definite Stent Thrombosis Up to 3 Years in the n-DES, o-DES, and BMS Groups
The curves showing the cumulative rates of stent thrombosis in the n-DES and o-DES groups start to diverge before 6 months postpercutaneous coronary intervention (PCI) with a further step-up in the o-DES group after 1 year. The rates of stent thrombosis in the BMS group increased constantly up to 3 years. Abbreviations as in Figure 1 .
New-Generation DES in STEMI 1.1% in the o-DES group and 1.5% in the BMS group.
The ST rate in the o-DES group increased by 0.6% during the second year and by 0.4% during the third year of follow-up. The very late ST risk up to 3 years was more than doubled in the o-DES group compared with the BMS group.
Most previous randomized studies (19, 22, 25, 26) failed to show any significant difference in the ST risk between DES and BMS, and this could be related to the limited statistical power inadequate to detect a small but statistically significant difference in lowfrequency events such as ST.
In the HORIZONS-AMI (Harmonizing Outcomes
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